Pfizer Inc. (PFE)

Basic

  • Market Cap

    $163.24B

  • EV

    $183.46B

  • Shares Out

    5,646.41M

  • Revenue

    $68.54B

  • Employees

    83,000

Margins

  • Gross

    54.63%

  • EBITDA

    20.35%

  • Operating

    11.45%

  • Pre-Tax

    15.2%

  • Net

    15.29%

  • FCF

    11.93%

Returns (5Yr Avg)

  • ROA

    6.52%

  • ROE

    24.7%

  • ROCE

    13.22%

  • ROIC

    11.27%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $40.41

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $12.16

  • Earnings (Dil)

    $1.84

  • FCF

    $1.43

  • Book Value

    $17.17

Growth (CAGR)

  • Rev 3Yr

    28.46%

  • Rev 5Yr

    5.13%

  • Rev 10Yr

    2.82%

  • Dil EPS 3Yr

    283.72%

  • Dil EPS 5Yr

    -14.26%

  • Dil EPS 10Yr

    2.49%

  • Rev Fwd 2Yr

    -20.57%

  • EBITDA Fwd 2Yr

    -26.69%

  • EPS Fwd 2Yr

    -30.71%

  • EPS LT Growth Est

    2.9%

Dividends

  • Yield

    —

  • Payout

    87.74%

  • DPS

    $1.63

  • DPS Growth 3Yr

    2.81%

  • DPS Growth 5Yr

    4%

  • DPS Growth 10Yr

    5.66%

  • DPS Growth Fwd 2Yr

    1.93%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

40,825.0

40,905.0

41,651.0

81,288.0

100,330.0

68,537.0

Total Revenues % Chg.

-22.3%

0.2%

1.8%

95.2%

23.4%

-31.4%

Cost of Goods Sold, Total

8,872.0

7,847.0

8,385.0

30,686.0

34,097.0

31,097.0

Gross Profit

31,953.0

33,058.0

33,266.0

50,602.0

66,233.0

37,440.0

Selling General & Admin Expenses, Total

12,149.0

12,766.0

11,418.0

9,562.0

12,200.0

13,575.0

R&D Expenses

7,713.0

7,721.0

8,709.0

10,360.0

11,428.0

11,420.0

Amortization of Goodwill and Intangible Assets

4,736.0

4,429.0

3,348.0

3,700.0

3,609.0

4,597.0

Other Operating Expenses, Total

24,598.0

24,916.0

23,475.0

23,622.0

27,237.0

29,592.0

Operating Income

7,355.0

8,142.0

9,791.0

26,980.0

38,996.0

7,848.0

Interest Expense, Total

-1,316.0

-1,573.0

-1,449.0

-1,291.0

-1,238.0

-1,834.0

Interest And Investment Income

586.0

445.0

351.0

202.0

565.0

1,890.0

Net Interest Expenses

-730.0

-1,128.0

-1,098.0

-1,089.0

-673.0

56.0

Income (Loss) On Equity Invest.

—

17.0

298.0

471.0

436.0

507.0

Currency Exchange Gains (Loss)

—

—

—

-192.0

-1,153.0

-166.0

Other Non Operating Income (Expenses)

1,009.0

1,365.0

1,639.0

1,997.0

2,619.0

1,406.0

EBT, Excl. Unusual Items

7,634.0

8,396.0

10,630.0

28,167.0

40,225.0

9,651.0

Restructuring Charges

-1,332.0

-1,093.0

-837.0

-1,360.0

-2,025.0

-1,740.0

Merger & Related Restructuring Charges

-19.0

-2.0

-58.0

-92.0

-200.0

-681.0

Gain (Loss) On Sale Of Investments

445.0

8,561.0

557.0

1,344.0

-1,273.0

-631.0

Gain (Loss) On Sale Of Assets

71.0

32.0

-237.0

99.0

—

230.0

Asset Writedown

-3,115.0

-2,792.0

-1,691.0

-86.0

-421.0

-485.0

In Process R&D Expenses

—

—

-684.0

-3,469.0

-953.0

-195.0

Legal Settlements

-84.0

-292.0

-28.0

-182.0

-230.0

-301.0

Other Unusual Items

-5.0

-1,490.0

-616.0

-111.0

-394.0

4,569.0

EBT, Incl. Unusual Items

3,595.0

11,320.0

7,036.0

24,310.0

34,729.0

10,417.0

Income Tax Expense

-266.0

583.0

370.0

1,852.0

3,328.0

-90.0

Earnings From Continuing Operations

3,861.0

10,737.0

6,666.0

22,458.0

31,401.0

10,507.0

Earnings Of Discontinued Operations

7,328.0

5,318.0

2,529.0

-434.0

6.0

13.0

Minority Interest

-36.0

-29.0

-36.0

-45.0

-35.0

-38.0

Net Income

11,153.0

16,026.0

9,159.0

21,979.0

31,372.0

10,482.0

Preferred Dividend and Other Adjustments

1.0

1.0

—

—

—

—

Net Income to Common Incl Extra Items

11,152.0

16,025.0

9,159.0

21,979.0

31,372.0

10,482.0

Net Income to Common Excl. Extra Items

3,824.0

10,707.0

6,630.0

22,413.0

31,366.0

10,469.0

Total Shares Outstanding

5,717.0

5,534.0

5,567.0

5,620.0

5,616.0

5,646.0

Weighted Avg. Shares Outstanding

5,872.0

5,569.0

5,555.0

5,601.0

5,608.0

5,635.0

Weighted Avg. Shares Outstanding Dil

5,977.0

5,675.0

5,632.0

5,708.0

5,733.0

5,721.8

EPS

1.9

2.9

1.6

3.9

5.6

1.9

EPS Diluted

1.9

2.8

1.6

3.9

5.5

1.8

EBITDA

13,467.0

13,857.0

14,455.0

32,084.0

44,024.0

13,945.0